WHO ICTRP trial
Staphylococcus albus tablets in the treatment of chronic cough with chronic…
ChiCTR2300073748 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300073748 |
|---|---|
| Public title | Staphylococcus albus tablets in the treatment of chronic cough with chronic inflammation in pre diabetes: a randomized controlled study |
| Scientific title | Staphylococcus albus tablets in the treatment of chronic cough with chronic inflammation in pre diabetes: a randomized controlled study |
| Primary sponsor | Beijing Friendship Hospital ,Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | pre-diabetes |
| Interventions | group C:health education;group ISE:health education + Staphylococcus albus tablets (4 tablets once, 4 times a day, orally) |
| Registration date | Jul 20, 2023 |
| Target size | group C:20;group ISE:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: